⌘K

Home/Filings/4/0001493152-24-023152

4//SEC Filing

Karah Hila 4

Accession 0001493152-24-023152

CIK 0001857044other

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:00 PM ET

Size

5.4 KB

Accession

0001493152-24-023152

Insider Transaction Report

Form 4

Period: 2024-06-06

Indaptus Therapeutics, Inc.INDP

Director

Transactions

Award
Stock Option (right to buy)
2024-06-06+12,500→ 12,500 total
Exercise: $2.63Exp: 2034-06-06→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable on June 6, 2025.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Indaptus Therapeutics, Inc.

CIK 0001857044

Entity typeother

Related Parties

1

filerCIK 0001668116

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 5:00 PM ET
Size: 5.4 KB

View on SEC.gov